Picture of Zur Rose AG logo

ROSE Zur Rose AG Share Price

0.000.00%
ch flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapValue Trap

Momentum

Relative Strength (%)
1m-18.46%
3m-47.78%
6m-66.17%
1yr-82.14%
Volume Change (%)
10d/3m+3.75%
Price vs... (%)
52w High-85.39%
50d MA-18.72%
200d MA-63.08%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-18.34%
Return on Equity-44.41%
Operating Margin-11.22%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueCH₣m982.921,207.111,355.541,476.931,726.51,742.982,230.614.44%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Zur Rose AG EPS forecast chart

Profile Summary

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Directors

Last Annual
December 31st, 2021
Last Interim
December 31st, 2021
Incorporated
April 6th, 1993
Public Since
July 6th, 2017
No. of Shareholders
10,063
No. of Employees
2,131
Sector
Food & Drug Retailing
Industry
Consumer Defensives
Exchange
ch flag iconSIX Swiss Exchange
Shares in Issue
10,394,279

ROSE Share Price Performance

Upcoming Events for ROSE

Half Year 2022 Zur Rose Group AG Earnings Release

Similar to ROSE

Picture of Galenica AG logo

Galenica AG

ch flag iconSIX Swiss Exchange

Picture of Villars Holding SA logo

Villars Holding SA

ch flag iconSIX Swiss Exchange

FAQ

Or unlock with your email

Or unlock with your email